An Open-Label, Expanded Access Protocol for Patients with Sickle Cell Disease Who Have No Alternative Treatment Options - GBT 440-037
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
October 15, 2019
End Date
October 26, 2023
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
October 15, 2019
End Date
October 26, 2023